Noncellular Immune Therapies for Non-Hodgkin Lymphoma
Author:
Funder
BMS
Genentech
Merck
Seattle Genetics
Pharmacyclics
Immune Design
Kite Pharma
Gilead Sciences
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference59 articles.
1. Overall survival benefit in patients with rituximab-refractory indolent non-Hodgkin lymphoma who received obinutuzumab plus bendamustine induction and obinutuzumab maintenance in the GADOLIN study;Cheson;J Clin Oncol,2018
2. Obinutuzumab for the first-line treatment of follicular lymphoma;Marcus;N Engl J Med,2017
3. Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large B-Cell lymphoma;Vitolo;J Clin Oncol,2017
4. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma;Ogura;J Clin Oncol,2014
5. Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study;Ishida;J Clin Oncol,2012
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy;Genes & Diseases;2024-01
2. Deciphering the role of CD47 in cancer immunotherapy;Journal of Advanced Research;2023-10
3. Addition of BTK inhibitor orelabrutinib to rituximab improved anti-tumor effects in B cell lymphoma;Molecular Therapy - Oncolytics;2021-06
4. A comprehensive retrospective cohort study of the journey of B-cell lymphoma in Taiwan;Scientific Reports;2021-05-12
5. Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma;International Journal of Molecular Sciences;2021-03-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3